This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Mosca, M Articles by Bombardieri, S Search for Related Content PubMed PubMed Citation Articles by Mosca, M Articles by Bombardieri, S Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CYCLOPHOSPHAMIDE METHYLPREDNISOLONE Social Bookmarking                         What's this?

Therapy with pulse methylprednisolone and short course pulse cyclophosphamide for diffuse proliferative glomerulonephritis

Clinical Immunology Unit, Internal Medicine Department, University of Pisa, via Roma 67, 56126 Pisa, Italy marta{at}sssup.it

R Neri

S Giannessi

Clinical Immunology Unit, University of Pisa, Pisa, Italy

A Pasquariello

R Puccini

Nephrology Unit, Santa Chiara Hospital, Pisa, Italy

W Bencivelli

S Bombardieri

Clinical Immunology Unit, University of Pisa, Pisa, Italy

The incidence of renal flares and the long-term outcome in a group of 33 systemic lupus erythematosus (SLE) patients with diffuse proliferative glomerulonephritis (DPGN) treated with pulse steroids and a short course of pulse cyclophosphamide (CYC) are evaluated. Fifteen patients (45%) experienced a flare of renal disease at some time after the discontinuation of the immunosuppressive (IS) therapy; among these half (24%) were ‘early’ flares occurring shortly after the discontinuation of therapy, and the other half (21%) were ‘late’ flares occurring more than 2 y after the discontinuation of the treatment. Nine patients (27%) showed a poor renal outcome at the end of follow-up. On multiple regression analysis, a younger age and a high activity index (AI) on renal histology were found to be correlated with the occurrence of renal flares. Our results suggest that the combination of pulse steroids with a short course of pulse CYC (six to nine pulses) is effective in both controlling disease activity and in preventing the occurrence of renal flares in DPGN. However, short term IS therapy might not be sufficient to maintain disease control in younger patients with active lesions on renal histology. Such patients might be candidates to receive more prolonged IS treatment.

Key Words: pulse methylprednisolone • pulse cyclophosphamide • diffuse proliferative glomerulonephritis • renal outcome • renal flares

Lupus, Vol. 10, No. 4, 253-257 (2001)
DOI: 10.1191/096120301680416931


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				Y. E. Chen, S. M. Korbet, R. S. Katz, M. M. Schwartz, E. J. Lewis, and for the Collaborative Study Group Value of a Complete or Partial Remission in Severe Lupus Nephritis Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 46 - 53. [Abstract] [Full Text] [PDF]

				C. Grootscholten and J. H. M. Berden Discontinuation of immunosuppression in proliferative lupus nephritis: is it possible? Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1465 - 1469. [Full Text] [PDF]

				P I Sidiropoulos, H D Kritikos, and D T Boumpas Lupus nephritis flares Lupus, January 1, 2005; 14(1): 49 - 52. [Abstract] [PDF]

				M Petri Cyclophosphamide: new approaches for systemic lupus erythematosus Lupus, May 1, 2004; 13(5): 366 - 371. [Abstract] [PDF]

				A. Della Rossa, C. Baldini, A. Tavoni, A. Tognetti, D. Neglia, G. Sambuceti, R. Puccini, C. Colangelo, and S. Bombardieri Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre Rheumatology, November 1, 2002; 41(11): 1286 - 1294. [Abstract] [Full Text] [PDF]